ALLMedicine™ Biliary Disease Center

Oct 16th, 2020 - Hepaticojejunostomy stricture (HJS) is commonly treated under double- or single balloon enteroscopic guidance [1, 2], although this approach has several disadvantages, such as prolonged procedure time. An endoscopic ultrasound (EUS)-guided approac...

Oct 14th, 2020 - Artificial intelligence is touted as the future of medicine. Classical algorithms for the detection of common bile duct stones (CBD) have had poor clinical uptake due to low accuracy. This study explores the challenges of developing and implementi...

Oct 3rd, 2020 - Most of the literature on emergency general surgery (EGS) has investigated appendiceal and biliary disease; however, EGS surgeons manage many other complex conditions. This study aimed to describe the operative burden of these conditions throughou...

Sep 6th, 2020 - Cholangiocarcinoma (CCA) is a malignant cancer of the biliary tract with a poor prognosis. Herein, we investigated possible mechanism of extrahepatic CCA (eCCA) by dysregulated iron metabolism and post-translational modifications (PTMs). Further, ...

Sep 4th, 2020 - Irreversible electroporation (IRE) is a relatively new ablation method. However, the application of IRE ablation in the treatment of biliary disease has not been attempted. A minimally invasive approach using endoscopic retrograde cholangiopancrea...

May 5th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

Jul 24th, 2012 - The Tokyo Guidelines for the management of acute cholangitis and cholecystitis were published in 2007 (TG07) and have been widely cited in the world literature. Because of new information that has been published since 2007, we organized the Tokyo ...

Oct 16th, 2020 - Hepaticojejunostomy stricture (HJS) is commonly treated under double- or single balloon enteroscopic guidance [1, 2], although this approach has several disadvantages, such as prolonged procedure time. An endoscopic ultrasound (EUS)-guided approac...

Oct 14th, 2020 - Artificial intelligence is touted as the future of medicine. Classical algorithms for the detection of common bile duct stones (CBD) have had poor clinical uptake due to low accuracy. This study explores the challenges of developing and implementi...

Oct 3rd, 2020 - Most of the literature on emergency general surgery (EGS) has investigated appendiceal and biliary disease; however, EGS surgeons manage many other complex conditions. This study aimed to describe the operative burden of these conditions throughou...

Sep 6th, 2020 - Cholangiocarcinoma (CCA) is a malignant cancer of the biliary tract with a poor prognosis. Herein, we investigated possible mechanism of extrahepatic CCA (eCCA) by dysregulated iron metabolism and post-translational modifications (PTMs). Further, ...

Sep 4th, 2020 - Irreversible electroporation (IRE) is a relatively new ablation method. However, the application of IRE ablation in the treatment of biliary disease has not been attempted. A minimally invasive approach using endoscopic retrograde cholangiopancrea...

Dec 12th, 2017 - Advances in Diagnosing Cholestasis Magnetic resonance cholangiopancreatography (MRCP) is traditionally the primary method used to establish a diagnosis of primary sclerosing cholangitis (PSC); however, data defining its prognostic utility are limi...

Feb 28th, 2006 - Action Points Explain to interested patients that a rare complication of an appendectomy is a mechanical obstruction of the bowel, sometimes caused by an inflammatory response that causes adhesions around the small bowel. Explain to patients who a...

The focus of liver and biliary disease research in the United States through 2015 has been set with the release of the National Institutes of Health's Action Plan for Liver Disease Research. The decade-long initiative is the result of coordinated.

The focus of liver and biliary disease research in the United States through 2015 has been set with the release of the National Institutes of Health's Action Plan for Liver Disease Research. The decade-long initiative is the result of coordinated.